The company's focus is on identifying healthcare companies led by seasoned management teams that have the potential to create long-term value. KBL believes that the convergence of biology, chemistry, physics, and computer science will lead to the creation of new paradigms in healthcare. They invest in major areas such as life sciences, medical devices, healthcare services, and medical information technology. In the life sciences space, KBL invests in biopharmaceuticals, drug discovery platforms, and advanced materials. In the medical device area, they seek companies that address large, unmet medical needs with demonstrated clinical benefits. KBL is based in New York and operates a blank check company.